InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,187.70
(
0.13%
)
US TECH 100
17,618.80
(
0.05%
)
Dow Jones
38,884.26
(
0.08%
)
Brent Oil
82.66
(
-0.25%
)
Bitcoin
62,974.85
(
1.03%
)
Post# of 251748
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Fuma102

Send PM Follow Ignore
Followers 0
Posts 12
Boards Moderated 0
Alias Born 09/13/2009

Fuma102

Re: jq1234 post# 129222

Friday, 11/04/2011 6:28:08 PM

Friday, November 04, 2011 6:28:08 PM

Post# of 251748
a little late on the PFE / INCY JAK debate, but here goes.


PFE med, BID PO dosing:
ACR20: 53%
ACR50: 35%
ACR70: 22%

(previous P2 data: 66/37/20 for ACR 20/50/70 respectively - the P3 numbers are actually worse)

INCY P2a data, once daily PO dosing:
ACR20: 72%
ACR50: 44%
ACR70: 30%

INCY & LLY have a better mousetrap. Too bad INCY only gets 20-30% royalties.

links somewhere in here: http://boards.fool.com/incy-re-eval-29468832.aspx
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up